EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Immunosuppression Does Not Appear to Affect Echinococcal Cyst Viability as Confirmed by Immunoblotting Test: A Case Report in a Lung Transplant Patient

Raffaella Lissandrin, Ambra Vola, Domenica Federica Briganti, Sofia Frattola, Armanda Leka, Elena Seminari, Enrico Brunetti

The American Journal of Tropical Medicine and Hygiene · 2026-11-10

DOI: 10.4269/ajtmh.26-0403 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT. A 61-year-old Italian woman was diagnosed with a CE4 echinococcal cyst in the seventh hepatic segment. The cyst was managed conservatively (“watch and wait”) as per WHO guidelines. Serology for Echinococcus granulosus (ELISA) was negative. Five years later, in September 2025, the patient underwent bilateral lung transplant for chronic obstructive pulmonary disease. Induction with basiliximab, steroids, and treatment with tacrolimus and mycophenolic acid was started. Serology for E. granulosus (ELISA, rapid test [RT], and immunoblotting [IB]) remained negative, and the patient was managed expectantly. Serology with ELISA, RT, and IB remained negative at 0, 1, 3, and 6 months posttransplant. The cyst remained unchanged at all time points. Although anecdotal, this finding supports the hypothesis that unlike alveolar echinococcosis, immunosuppression has no effect on the viability of E. granulosus cysts. This has important clinical consequences. The American Society of Transplantation suggests treating patients for cystic echinococcosis before transplantation, and for adequate candidates, it recommends surgical removal with perioperative albendazole, an approach not supported by the literature. The need for treatment or surgical management of cystic echinococcosis in immunocompromised patients should be reconsidered.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →